Rafferty Asset Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
KCM
VCM
AVM
OCA
SB
SL
Rafferty Asset Management's GOSS Position: Q1 2026 in Review
Rafferty Asset Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 312,804 shares — an estimated $970K sold.
Rafferty Asset Management first reported a position in GOSS in Q4 2019 and held it in 13 quarters. The position peaked at $6.01M in Q4 2022. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.
- Rafferty Asset Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
- Rafferty Asset Management sold 312,804 Gossamer Bio shares in Q1 2026, an estimated $970K.
- Rafferty Asset Management first reported a position in Gossamer Bio in Q4 2019 and held it in 13 quarters.
- Rafferty Asset Management's Gossamer Bio position peaked at $6.01M in Q4 2022.
- 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.